Expectations trend
FY2028 · fiscal year ending 2028-06-30 · fmp
Trio-Tech International (TRT)
AMEXInformation TechnologySemiconductorsSnapshot 2026-11-04
$4.96+2.27%
Close 2026-11-04 · 1-day change
AMEXInformation TechnologySemiconductorsSnapshot 2026-11-04
The long-term thesis, the evidence coming in, and the environment around it. Thesis dated Jul 8, 2026.
Next-FY EPS estimate change · 30 days
0.40 → 0.40 EPS · FY ending Jun 30, 2028 · 1 analyst
One observable signal. This measures changing earnings expectations, not the probability of a gain or loss.
Change in the same fiscal period’s mean EPS estimate from Oct 5, 2026 to Nov 4, 2026: (new ÷ prior − 1). Contributor count changed from 1 to 1; this is not the number of analysts revising. The ±10% axis is a display range.
The EPS and P/E reference is not available for TRT yet.
| Measure / period | Management expectations | Analyst expectations |
|---|
Management figures unavailable.
Current consensus figures unavailable.
Three published thesis conditions, with dated milestones shown separately.
| Key Factor | Why It Matters | Current Status | Break Condition | Latest Evidence |
|---|---|---|---|---|
Issue shares for capital raising | Management is raising capital to support growth. | Intact | Capital raise fails or proceeds not deployed by 2026-H1 | Capital raise completed (1.05M shares) vs target by 2026-H1 April 2026 securities purchase agreement for 1,052,632 shares; May 2026 lease agreement signed. Nov 4, 2026Last status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Compare these dated observations with the operating requirements above
FY2028 · fiscal year ending 2028-06-30 · fmp
The evidence, the remaining questions, and what comes next
No recovery evidence is reported in the available driver assessments.
Nov 13, 2026
Look for updated results and guidance against the published targets, plus direct evidence for unresolved drivers.
Review earningsObserved price history; separate from operating scenarios
The weekly editorial context below is a separate assessment from the dated monitor evidence above. Recovery observations do not automatically change the published thesis. Unverified outside influences are hypotheses, not measured driver evidence.
TRT is a high-risk, loss-making growth business, not an established compounder. Its thesis is in a watch state: semiconductor back-end revenue has grown, but operating results weakened and recent performance trails its industry cohort.
The valuation signal is mixed: TRT is described as cheap versus peers, while a separate measure shows a 16% premium to peers. The model has low confidence, and the negative expectations gap points to limited room for disappointment; the priced-in assessment is tagged justified, with low fragility.
Over the multi-year view, semiconductor back-end revenue growth and Malaysian capacity expansion support the growth case, but operating results shifted from income to a loss. Industrial Electronics grew for fiscal 2026, though fourth-quarter revenue declined year over year. Near term, a guidance cut is a stated risk, and the recent legal or listing-rule notice adds uncertainty.
The central question is whether semiconductor testing growth and added capacity can translate into improved operating results. A guidance cut would weaken the case; rate cuts or steadier results and guidance from major technology companies could support the sector backdrop. Evidence for these forward scenarios is limited.
The 1-to-3-year view remains uncertain: revenue growth is real, but profitability, execution, and high risk remain unresolved. Not investment advice.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
| The company is expanding with new leased space. |
| Intact |
| Lease agreement not operational or delayed beyond 2026-H1 |
Lease executed Apr 2026, effective Jun 1, 2026 Company entered a lease for 104,000 sq ft effective June 1, 2026, confirming execution and operational status within the target window. Nov 4, 2026Last status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Increase demand for semiconductor testing services | Trio-Tech grew revenue 124% in Q3, showing strong demand for testing services. | Broken | revenue falls below $15M in any quarter through 2026-Q3 | Direct metric needs a verified mapping The published measure or accounting basis is not supported by an exact source binding. Date unavailableLast status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Stored thesis · Jul 8, 2026. Latest Evidence uses source-matched measurements where available, alongside the last thesis-monitor assessment. Source periods and assessment dates are shown separately. A new measurement does not automatically change the published status or verify an older target.
$0.40 → $0.40 · observed estimates
$0.10B → $0.10B · observed estimates
One fiscal period and provider throughout. At least five contributors are required for each plotted metric; missing coverage stays a gap. Axes show the observed range. Counts measure coverage, not revisions.
| Snapshot | EPS | Revenue | EPS / revenue analysts |
|---|---|---|---|
| 2026-09-30 | $0.40 | $99,543,000 | 1 / 1 |
| 2026-10-01 | $0.40 | $99,543,000 | 1 / 1 |
| 2026-10-02 | $0.40 | $99,543,000 | 1 / 1 |
| 2026-10-03 | $0.40 | $99,543,000 | 1 / 1 |
| 2026-10-04 | $0.40 | $99,543,000 | 1 / 1 |
| 2026-10-05 | $0.40 | $99,543,000 | 1 / 1 |
| 2026-10-06 | $0.40 | $99,543,000 | 1 / 1 |
| 2026-10-07 | $0.40 | $99,543,000 | 1 / 1 |
| 2026-10-08 | $0.40 | $99,543,000 | 1 / 1 |
| 2026-10-09 | $0.40 | $99,543,000 | 1 / 1 |
| 2026-10-10 | $0.40 | $99,543,000 | 1 / 1 |
| 2026-10-11 | $0.40 | $99,543,000 | 1 / 1 |
| 2026-10-12 | $0.40 | $99,543,000 | 1 / 1 |
| 2026-10-13 | $0.40 | $99,543,000 | 1 / 1 |
| 2026-10-14 | $0.40 | $99,543,000 | 1 / 1 |
| 2026-10-15 | $0.40 | $99,543,000 | 1 / 1 |
| 2026-10-16 | $0.40 | $99,543,000 | 1 / 1 |
| 2026-10-17 | $0.40 | $99,543,000 | 1 / 1 |
| 2026-10-18 | $0.40 | $99,543,000 | 1 / 1 |
| 2026-10-19 | $0.40 | $99,543,000 | 1 / 1 |
| 2026-10-20 | $0.40 | $99,543,000 | 1 / 1 |
| 2026-10-21 | $0.40 | $99,543,000 | 1 / 1 |
| 2026-10-22 | $0.40 | $99,543,000 | 1 / 1 |
| 2026-10-23 | $0.40 | $99,543,000 | 1 / 1 |
| 2026-10-24 | $0.40 | $99,543,000 | 1 / 1 |
| 2026-10-25 | $0.40 | $99,543,000 | 1 / 1 |
| 2026-10-26 | $0.40 | $99,543,000 | 1 / 1 |
| 2026-10-27 | $0.40 | $99,543,000 | 1 / 1 |
| 2026-10-28 | $0.40 | $99,543,000 | 1 / 1 |
| 2026-10-29 | $0.40 | $99,543,000 | 1 / 1 |
| 2026-10-30 | $0.40 | $99,543,000 | 1 / 1 |
| 2026-10-31 | $0.40 | $99,543,000 | 1 / 1 |
| 2026-11-01 | $0.40 | $99,543,000 | 1 / 1 |
| 2026-11-02 | $0.40 | $99,543,000 | 1 / 1 |
| 2026-11-03 | $0.40 | $99,543,000 | 1 / 1 |
| 2026-11-04 | $0.40 | $99,543,000 | 1 / 1 |
Revenue and EPS estimates track expectations. They are not delivered results or like-for-like proof of a required annual path.
Latest: 1 Buy / Strong Buy · 0 Hold · 0 Sell / Strong Sell
Recent actions · Oct 6–Nov 4 · 0 recorded
Individual price-target observations are unavailable.
0 raises · 0 cuts · 0 unchanged · 0 without a comparable prior
Oct 6, 2026–Nov 4, 2026. Each firm's latest positive target is paired only with its immediately prior positive target from the same provider, at most 180 days earlier. Unmatched observations have one dot; conflicting observations are not compared.
1 of 3 published conditions remain under pressure or need verification. The next results need to address those conditions.
The dated weekly assessment and its assumptions are available in Read detailed Outlook.